REQUEST A DEMO
Total
USD $0.00
Search more companies

Sherleg Laboratories S A S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Sherleg Laboratories S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Sherleg Laboratories S A S is an enterprise based in Colombia. Its main office is in Bogota D.C.. It operates in the Pharmaceutical Preparation Manufacturing sector. It was established on July 19, 2012. The total number of employees is currently 178 (2024). The latest financial highlights indicate a net sales revenue increase of 11.14% in 2023. Its total assets grew by 4.59% over the same period. The net profit margin of Sherleg Laboratories S A S increased by 5.26% in 2023.

Headquarters
Cr 68D 17A 80
Bogota D.C.; Bogota D.C; Postal Code: 0617

Contact Details: Purchase the Sherleg Laboratories S A S report to view the information.

Basic Information
Total Employees:
Purchase the Sherleg Laboratories S A S report to view the information.
Outstanding Shares:
Purchase the Sherleg Laboratories S A S report to view the information.
Incorporation Date:
July 19, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Sherleg Laboratories S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
11.14%
Total operating revenue
11.14%
Operating profit (EBIT)
36.14%
EBITDA
32.85%
Net Profit (Loss) for the Period
59.47%
Total assets
4.59%
Total equity
21.55%
Operating Profit Margin (ROS)
5.45%
Net Profit Margin
5.26%
Return on Equity (ROE)
4.22%
Debt to Equity Ratio
-18.78%
Quick Ratio
1.7%
Cash Ratio
0.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?